ArticleTravel medicine and infectious disease
COVID-19 treatment in sub-Saharan Africa: If the best is not available, the available becomes the best.
Article in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Public health system in post-pandemic Sierra Leone: a scoping review.BMC infectious diseases · 2024Article
- Spatio-temporal dynamic of the COVID-19 epidemic and the impact of imported cases in Rwanda.BMC public health · 2023Article
- Article
- COVID-19 preparedness and social dynamics in a Sub-Saharan Africa country, Benin.Health promotion international · 2022Article
- "An increase in COVID-19 patients would be overwhelming": A qualitative description of healthcare workers' experiences during the first wave of COVID-19 (March 2020 to October 2020) at Malawi's largest referral hospital.Wellcome open research · 2022Article
- Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2021Article
- Article
- Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.Journal of global antimicrobial resistance · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.